Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Van Laar

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
FEBS Letters|March 10, 2000
The novel MMS-inducible gene Mif1/KIAA0025 is a target of the unfolded protein response pathwayT van Laar, T Schouten, E Hoogervorst, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 16, 2007
[Epigenetic processes in malignant transformation: the role of DNA methylation in cancer development]K P M Suijkerbuijk, E van der Wall, T van Laar, et al.
Neuropsychological Rehabilitation|February 20, 2015
Parkinson's patients' executive profile and goals they set for improvement: Why is cognitive rehabilitation not common practice?T T Vlagsma, J Koerts, L Fasotti, et al.
Virology|October 1, 1995
Distinct modulation of p53 activity in transcription and cell-cycle regulation by the large (54 kDa) and small (21 kDa) adenovirus E1B proteinsW T Steegenga, T Van Laar, A Shvarts, et al.
Annals of Clinical Biochemistry|July 26, 2024
Automated tools for identifying the causes of anaemia in general practices are particularly advantageous for patients who do not fit the typical profileBauke A de Boer, Tatum T van Laar, Firmin Candido, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|February 4, 1998
Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's diseaseR van der Geest, P Kruger, J M Gubbens-Stibbe, et al.
Parkinsonism & Related Disorders|May 20, 2015
Parkinson bradykinesia correlates with EEG background frequency and perceptual forward projectionM Beudel, E Roosma, O E Martinez Manzanera, et al.
Clinical Neuropharmacology|June 9, 1998
Stepwise intravenous infusion of apomorphine to determine the therapeutic window in patients with Parkinson's diseaseT van Laar, R van der Geest, M Danhof, et al.
FEBS Letters|January 11, 2001
cDNA micro array identification of a gene differentially expressed in adenovirus type 5- versus type 12-transformed cellsA C Vertegaal, H B Kuiperij, T van Laar, et al.
Parkinsonism & Related Disorders|February 8, 2006
Chronic stimulation of the subthalamic nucleus increases daily on-time without dyskinesia in advanced Parkinson's diseaseA T Portman, T van Laar, M J Staal, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
FEBS Letters|March 10, 2000
The novel MMS-inducible gene Mif1/KIAA0025 is a target of the unfolded protein response pathwayT van Laar, T Schouten, E Hoogervorst, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 16, 2007
[Epigenetic processes in malignant transformation: the role of DNA methylation in cancer development]K P M Suijkerbuijk, E van der Wall, T van Laar, et al.
Neuropsychological Rehabilitation|February 20, 2015
Parkinson's patients' executive profile and goals they set for improvement: Why is cognitive rehabilitation not common practice?T T Vlagsma, J Koerts, L Fasotti, et al.
Virology|October 1, 1995
Distinct modulation of p53 activity in transcription and cell-cycle regulation by the large (54 kDa) and small (21 kDa) adenovirus E1B proteinsW T Steegenga, T Van Laar, A Shvarts, et al.
Annals of Clinical Biochemistry|July 26, 2024
Automated tools for identifying the causes of anaemia in general practices are particularly advantageous for patients who do not fit the typical profileBauke A de Boer, Tatum T van Laar, Firmin Candido, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|February 4, 1998
Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's diseaseR van der Geest, P Kruger, J M Gubbens-Stibbe, et al.
Parkinsonism & Related Disorders|May 20, 2015
Parkinson bradykinesia correlates with EEG background frequency and perceptual forward projectionM Beudel, E Roosma, O E Martinez Manzanera, et al.
Clinical Neuropharmacology|June 9, 1998
Stepwise intravenous infusion of apomorphine to determine the therapeutic window in patients with Parkinson's diseaseT van Laar, R van der Geest, M Danhof, et al.
FEBS Letters|January 11, 2001
cDNA micro array identification of a gene differentially expressed in adenovirus type 5- versus type 12-transformed cellsA C Vertegaal, H B Kuiperij, T van Laar, et al.
Parkinsonism & Related Disorders|February 8, 2006
Chronic stimulation of the subthalamic nucleus increases daily on-time without dyskinesia in advanced Parkinson's diseaseA T Portman, T van Laar, M J Staal, et al.
Pageof 7